<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00253058</url>
  </required_header>
  <id_info>
    <org_study_id>104912</org_study_id>
    <nct_id>NCT00253058</nct_id>
  </id_info>
  <brief_title>Study Of Perennial Allergic Rhinitis In Pediatrics</brief_title>
  <official_title>Evaluation of the Efficacy and Safety of Cetirizine Dry Syrup in Children -Suffering From Perennial Allergic Rhinitis-</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GlaxoSmithKline</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To verify of cetirizine dry syrup to ketotifen dry syrup in the change of total nasal symptom
      score (TNSS) over the total treatment period from the score of the baseline assessment period
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2005</start_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in the total nasal symptom score (TNSS)</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>- Individual daily nasal symptom score - Investigator global improvement/patient global improvement - Nasal findings - Cetirizine serum concentrations - Adverse events</measure>
  </secondary_outcome>
  <enrollment>286</enrollment>
  <condition>Rhinitis, Allergic, Perennial</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cetirizine Dry Syrup</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children with perennial allergic rhinitis.

          -  Giving informed consent.

          -  Children with a positive response to specific IgE antibody test.

          -  Children assessed as positive in the nasal eosinophil count.

          -  Children whose severity score of nasal symptom is 4 or higher.

        Exclusion criteria:

          -  have spastic disease such as epilepsy

          -  have a history of drug hypersensitivity

          -  are pregnant, lactating or possibly pregnant female Children

          -  are sensitive to pollen as a duplicate allergen and whose treatment periods are
             thought in the pollen dispersion periods

          -  have vasomotor rhinitis and eosinophilic rhinitis

          -  have asthma that requires the treatment with corticosteroid

          -  have inappropriate complication of nasal disorder that may influence on the evaluation
             of the study drugs

          -  have complicated with atopic dermatitis or urticaria that requires the treatment with
             antihistamine preparation

          -  have started specific desensitization treatment or nonspecific modulation treatment
             but who have not reached the maintenance level of treatment

          -  have received surgical treatment for reduction and modulation of nasal mucosa

          -  redintegration therapy of nasal cavity to improve the degree of nasal airway

          -  surgical operation to improve rhinorrhea.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GSK Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>GlaxoSmithKline</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
    </facility>
  </location>
  <removed_countries>
    <country>Japan</country>
  </removed_countries>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 11, 2005</study_first_submitted>
  <study_first_submitted_qc>November 14, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2005</study_first_posted>
  <last_update_submitted>May 3, 2013</last_update_submitted>
  <last_update_submitted_qc>May 3, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 6, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Allergic</keyword>
  <keyword>pediatric</keyword>
  <keyword>Rhinitis</keyword>
  <keyword>Perennial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Rhinitis, Allergic</mesh_term>
    <mesh_term>Rhinitis, Allergic, Perennial</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cetirizine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

